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LETTERS TO THE EDITOR 
The Spoof Factor 
The precise incidence of recurrence after percutaneous transluminal 
coronary angioplasty and percutaneous transluminal angioplasty in 
peripheral arteries is unknown. As the various reports become 
available. however. it does appear that restenosis and reocclusion 
are occurring at disturbingly high levels in both circulations, ranging 
up to 40% in the first 6 months for the coronary arteries (I-1 I ). 
Angioplasty. regardless of the method used. results in injury to 
the vessel wall. Indeed. an angioplasty doctrine dictates that unless 
the arterial lining with its adherent plaque is injured. there can be no 
positive angioplastic, result. We glibly speak of “controlled” injury, 
the theoretical situation in which the physician creates the exact 
amount of injury sufficient to open the arterial channel but not to the 
extent that excessive damage might be created. However. we are 
now better able to appreciate the ramificationx when a plaque is 
expanded. fractured or in some way modified by transluminal 
manipulation. 
When one considers the aLerage angioplasty procedure. this 
concept of “controlled injury” can be only theoretical. never 
practical. For one thing. the variables are too numerous-balloon 
dimensions, inflation pressure and time, single versus multiple 
dilatations and the nature of the lesion itself. Carrying significant 
weight also are the variations in technique inherent with multiple 
operators. each of whom believes that he or she has just the right 
“touch” and the “formula” for success. It is possible that this 
individuality has deterred our scientific study of the recurrence 
problem and perhaps has even been a contributing factor in itself. 
To any student of atherosclerotic pathology and atherogenesis. 
these disappointing results with angioplasty are not too surprising 
considering the multifactorial nature of the problem. What is of 
interest, however. 19 how the angioplaster has been lulled into 
complacency by the .s~~f’,fuc~ro~. 
Since the first chnical angioplasty, the gold standard for imme- 
diate assessment of the result has been and continues today to be 
fluoroscopy with contrast injection often followed by the control 
arteriogram. Before the procedure is terminated and declared a 
success. this arteriographic control image must look esthetically 
acceptable. ‘This is the source of the spoof factor. 
Whereas the angioplaster is content with this pretty picture. the 
actual results of the procedure when viewed directly by way of an 
angioscope often arc dramatically different. Instead of the smooth 
intimal lining with perhaps minor evidence of dissection, direct 
visualization bears witness to what can be described as a war zone. 
Cracks. crevices. hemorrhage. thrombotic material and intimal flaps 
are observed in a myriad of configurations in nearly every angio- 
plasty no matter hou, “successful” the arteriogram appears. 
Those few investigators who have become proficient enough 
with angioplasty to produce consistently good pictures have recog- 
nized this discrepancv. However. the majority of angioplasters have 
been deceiced b\ the angiograms-spoofed into thinking the result 
is far more satisfactory than is actually the case. 
Acknowledgment of this factor assumes particular significance 
when we begin to gather follow-up information on the results of the 
various new angioplasty techniques under investigation. For exam- 
ple. there should be no surprise that the recurrence rate after 
atherect0rr.y with the Simpson device approaches that of balloon 
dilation alone. or that hot-tip (thermal) angioplasty results are less 
favorable than early. short-term data would have indicated. In truth. 
regardless of the technique used, the angioplasty procedure is not 
accomplishing what the final control arteriogram indicates. so we 
can expect only less than satisfactory long-term results. 
Recognition of the spoof factor should be the impetus for 
accelerated research into more accurate methods of assessing 
angioplasty results. Certainly, intravascular ultrasound imaging 
appears to be at least a potential technological advancement. Other 
modalities must be explored. Until then. we must recognize the 
limitations of our current gold standard and accept the restriction 
that it imposes on our assessment of angioplast) results. 
I. 
2. 
3 
4. 
6 
7. 
8. 
9. 
IO. 
II. 
References 
Holme\ DR. Vktstra RE. Smith HC. et al. Reatenosk after percutaneous translummal 
coronary angioplaaty IPTCAI: a report from the FTCA registry of the NatIonal Heart. 
Lung. and Blood fn\titute. .4m J Cardlol 1984:53’77C-XIC. 
Mata LA. Bosch X. Dwid PR. Rapold KJ. Corcob T. Bou~aw MG. Clmical and 
angiographlc a,ieasment 6 months after double verwl percutaneous coronary angio- 
p&v. J Am Coil C‘irdiol 1985:6: 1239-44. 
Ix\me S. EweI\ (‘J. Rosing DR. Kent KM. Coronan angwpla\ty: chmcal and 
.mglographlc follow-up. Am J Cardiol lY85:55:673-6. 
Lemlgruber PP. Roubin GS, Hollman I. et al. Restenow after auccersful coronar! 
.mgioplasty m patient\ wth single-ve\\el disease. Clrculatlon 1986:73:710-7. 
Roubm GS. Kmg SB. Douglas JS. Restenobia after percutaneous transluminal coro- 
oar) angwplastv: the Emory Umverrity Horpital evperwce Am J Cardiol 1987: 
ho:3YB43B. 
Vandormael MC. Dehgonul U. Kern MJ. Kennedy H. G&n K, Chaltman B. 
Restenow after multiletion percutaneous transluminal coronary angioplacty. Am J 
c’ardiol 198?.60~44B-7B 
Val PG. Bourarsa MG. David PK. et al. Reateka after *ucce\\ful percutaneou\ 
transluminal coronary angioplarty: the Montreal Heart Institute experience. Am J 
(‘ardiol I987:60~5OB-SB. 
km,t SMPG. van der Feltr TA. Bal ET, et al. Long-term angiographlc follow-up, 
cardiac ewnts. and wrwval in patients undergoing percutaneous transluminal coro- 
nary angioplast). Br Heart J lY87:57:!?0-5. 
Bussman W. Kdltenbach M. Kober G. Vallbracht C. The Frankfurt expenence in 
reQenocl\ after coronary angloplaaty. Am J Cardiol 1987:60:48B-9B. 
McBride W. Lange R.4, Hdhs LA. Rertenoals after wccr\rfuui coronary angloplaaty. N 
Fngl J Med 1988:3IX:1734-7. 
Kmg SB. Percutaneuu\ tranbluminal coronary angloplast)’ the recond decade. Am J 
(‘ardlol 19X8:h?~!K_(,K. 
01989 by the American Collcgc of Cardiology 
